IPS cells were named the breakthrough of 2008From Times Online:
The medical potential of reprogrammed stem cells that do not require the destruction of embryos has been exaggerated, according to the head of one of the world’s leading regenerative medicine companies.
Thomas Okarma, the chief executive of Geron Corporation, told The Times that while so-called induced pluripotent stem (IPS) cells will be extremely useful in research, they are unlikely to be suitable for transplanting to patients to treat disease.
Read more ....
No comments:
Post a Comment